At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery
In Brief
A clinical study evaluating Image-Guided Adaptive Radiation Therapy, Quality-of-Life Assessment, and 2 other interventions for Melanoma and 4 related conditions. Completed, enrolled 24 participants across 1 site.
Detailed Summary
This pilot clinical trial studies adaptive staged stereotactic body radiation therapy (SBRT) in treating patients with spinal metastases that cannot be removed by surgery. SBRT is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may kill more tumor cells and cause less damage to normal tissue. Adaptive SBRT uses information gathered during treatment to inform, guide, and alter future radiation treatments. Staged SBRT uses multiple treatments separated by 2-3 weeks. Giving adaptive staged SBRT may work better in treating spinal metastases that cannot be removed by surgery.
Study Details
Timeline
Interventions
Undergo adaptive staged SBRT
Ancillary studies
Ancillary studies
Undergo adaptive staged SBRT